Home

катедрала да се избегне контрольор nmd pharma claus olesen на почивка плач Луна

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

NMD Pharma
NMD Pharma

Initiator Pharma
Initiator Pharma

NMD Pharma
NMD Pharma

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Initiator Pharma
Initiator Pharma

Claus Elsborg Olesen - Biography
Claus Elsborg Olesen - Biography

UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular  Disease Mentor 1 Pontus Gourdon, MSc & PhD,
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Claus OLESEN | Aarhus University | AU | Department of Biomedicine
Claus OLESEN | Aarhus University | AU | Department of Biomedicine

Company Presentation
Company Presentation

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

Initiator Pharma
Initiator Pharma

AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders -  The Lens - Free & Open Patent and Scholarly Search
AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders - The Lens - Free & Open Patent and Scholarly Search

NMD Pharma
NMD Pharma

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Prominent Canadian researcher in Denmark: Why I left a top job in California
Prominent Canadian researcher in Denmark: Why I left a top job in California

WO2016202341A1 - Compounds for use in treating neuromuscular disorders -  Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents